Chemotherapy and Regional Therapy of Hepatic Colorectal Metastases: Expert Consensus Statement
- 6 September 2006
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 13 (10) , 1284-1292
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal AdenocarcinomaJournal of Clinical Oncology, 2005
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overviewCancer Treatment Reviews, 2004
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liverBritish Journal of Surgery, 2003
- Should Dukes' B patients receive adjuvant therapy? A statistical perspectiveSeminars in Oncology, 2001
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerThe Lancet, 1998
- Reversible hepatic steatosis in patients treated with interferon alfa-2A and 5-fluorouracilCancer, 1995